Diane Hershock, MD
Incyte Corporation
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Diane Hershock, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:33 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04586244 · An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial CarcinomaIncyte Corporation · terminated · Urothelial Carcinoma · study director
- Ph1NCT03522142 · A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced MalignanciesIncyte Corporation · terminated · Advanced Solid Tumors · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.